At least 5 agents that target the peroxisome
proliferator-activated receptor (PPAR) are in clinical studies in
primary biliary cholangitis (PBC). Are you aware of the latest
data?
Credit available for this activity expires: 2/21/2024
Earn Credit / Learning Objectives & Disclosures:
Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.